150 related articles for article (PubMed ID: 16618727)
1. Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens.
Li HR; Wang-Rodriguez J; Nair TM; Yeakley JM; Kwon YS; Bibikova M; Zheng C; Zhou L; Zhang K; Downs T; Fu XD; Fan JB
Cancer Res; 2006 Apr; 66(8):4079-88. PubMed ID: 16618727
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA
Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
[TBL] [Abstract][Full Text] [Related]
5. On selecting mRNA isoform features for profiling prostate cancer.
Nair TM
Comput Biol Chem; 2009 Dec; 33(6):421-8. PubMed ID: 19889581
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
Bainbridge MN; Warren RL; Hirst M; Romanuik T; Zeng T; Go A; Delaney A; Griffith M; Hickenbotham M; Magrini V; Mardis ER; Sadar MD; Siddiqui AS; Marra MA; Jones SJ
BMC Genomics; 2006 Sep; 7():246. PubMed ID: 17010196
[TBL] [Abstract][Full Text] [Related]
7. Cancer gene profiling in prostate cancer.
Foye A; Febbo PG
Methods Mol Biol; 2010; 576():293-326. PubMed ID: 19882268
[TBL] [Abstract][Full Text] [Related]
8. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
Sørensen KD; Ørntoft TF
Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
[TBL] [Abstract][Full Text] [Related]
9. ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy tissue sections.
Kieffer N; Schmitz M; Plançon S; Margue C; Huselstein F; Grignard G; Dippel W; Nathan M; Giacchi S; Scheiden R
Int J Oncol; 2005 Jun; 26(6):1549-58. PubMed ID: 15870868
[TBL] [Abstract][Full Text] [Related]
10. Expression signatures that correlated with Gleason score and relapse in prostate cancer.
Bibikova M; Chudin E; Arsanjani A; Zhou L; Garcia EW; Modder J; Kostelec M; Barker D; Downs T; Fan JB; Wang-Rodriguez J
Genomics; 2007 Jun; 89(6):666-72. PubMed ID: 17459658
[TBL] [Abstract][Full Text] [Related]
11. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
12. Profiling alternative splicing on fiber-optic arrays.
Yeakley JM; Fan JB; Doucet D; Luo L; Wickham E; Ye Z; Chee MS; Fu XD
Nat Biotechnol; 2002 Apr; 20(4):353-8. PubMed ID: 11923840
[TBL] [Abstract][Full Text] [Related]
13. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.
Huang D; Casale GP; Tian J; Wehbi NK; Abrahams NA; Kaleem Z; Smith LM; Johansson SL; Elkahwaji JE; Hemstreet GP
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1371-81. PubMed ID: 17623804
[TBL] [Abstract][Full Text] [Related]
14. Identification of gene signatures for invasive colorectal tumor cells.
Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
[TBL] [Abstract][Full Text] [Related]
15. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
16. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
[TBL] [Abstract][Full Text] [Related]
17. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
18. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
20. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
